Jens Eckstein

Jens Eckstein currently serves as a Member of the Board of Directors at Vandria SA and the Hevolution Foundation as an Investment Partner. Since June 2019, Jens has held dual roles as Managing Partner and Member of the Board of Advisors at Apollo Health Ventures, focusing on interventions to enhance healthy lifespan. Other notable positions include President and Member of the Board of Directors at Galilei Biosciences, Chairman at Booster Therapeutics and Refoxy Pharma, and Advisor at Thymofox. Jens is also an Angel Investor and Board Member at bosWell, a Kauffman Fellow since 2005, and has served as a Non-Executive Director at Imugene Limited until November 2024. Jens Eckstein’s academic background includes a Ph.D. in Biological Chemistry from the University of Konstanz and a Postdoctoral Fellowship at the University of California, San Francisco.